Abstract |
N6-2-(4-aminophenyl)ethyladenosine ( APNEA) is a nonselective adenosine receptor agonist known to have a high affinity for the adenosine A1 and A3 receptors. It was found to be able to dose-dependently increase the sustained (4 min) Ca2+ influx into rat cortical synaptosomes while 2-chloro-N6-(3-iodobenzyl)-adenosine-5-N-methyluronamide (Cl- IB-MECA), a selective A3 agonist has no effect. However, this effect of APNEA was not affected by the presence of 8-cyclopentyl-1,3-dimethylxanthine ( CPT), a selective A1 antagonist; but instead completely abolished by 8-(3-chlorostyryl)caffeine (CSC), a selective A2a antagonist, or omega-conotoxin GVIA. These results show that in the rat cortex, presynaptic A2a receptors can mediate neurotransmitter release by increasing Ca2+ influx through the N-type calcium channels. A1 and A3 receptors appear not to be involved.
|
Authors | S N Li, P T Wong |
Journal | Neurochemical research
(Neurochem Res)
Vol. 25
Issue 4
Pg. 457-9
(Apr 2000)
ISSN: 0364-3190 [Print] United States |
PMID | 10823578
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 1,3-dimethyl-8-cyclopentylxanthine
- Calcium Channel Blockers
- Calcium Channels, N-Type
- N(6)-2-(4-aminophenyl)ethyladenosine
- Purinergic P1 Receptor Agonists
- Purinergic P1 Receptor Antagonists
- Receptor, Adenosine A2A
- Receptor, Adenosine A3
- Receptors, Purinergic P1
- Xanthines
- 8-(3-chlorostyryl)caffeine
- Caffeine
- omega-Conotoxin GVIA
- Adenosine
- Calcium
- 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide
|
Topics |
- Adenosine
(analogs & derivatives, pharmacology)
- Animals
- Brain Chemistry
- Caffeine
(analogs & derivatives, pharmacology)
- Calcium
(metabolism)
- Calcium Channel Blockers
(pharmacology)
- Calcium Channels, N-Type
(drug effects, metabolism)
- Cerebral Cortex
(chemistry, drug effects, metabolism)
- Dose-Response Relationship, Drug
- Male
- Purinergic P1 Receptor Agonists
- Purinergic P1 Receptor Antagonists
- Rats
- Rats, Sprague-Dawley
- Receptor, Adenosine A2A
- Receptor, Adenosine A3
- Receptors, Purinergic P1
(metabolism)
- Synaptosomes
(drug effects, metabolism)
- Xanthines
(pharmacology)
- omega-Conotoxin GVIA
(pharmacology)
|